发明名称 PHENOTYPIC EFFECTS OF UBIQUINONE DEFICIENCIES AND METHODS OFSCREENING THEREOF
摘要 The present invention relates to a method of screening for a compound allowi ng survival of clk1 homozygous mutant embryos; a method of screening for a compound suitable for rescue of mutant phenotype of mclk1 homozygous cell line; a method of screening for a compound suitable for partial or complete functional replacement of endogenous ubiquinone; a method for screening a compound capable of inhibiting activity of clk-1 and/or other processes required to make ubiquinone from demethoxyubiquinone; a non-ubiquinone- producer mouse; a DNA construct, which comprises an alteration of mclk1; a n on- ubiquinone-producer ES cell line; a coq-3 mutant subject non-ubiquinone producer; a method of screening for a compound suitable for complete or partial functional ubiquinone or demethoxyubiquinone replacement; a method f or reducing and/or increasing ubiquinone level in a multicellular subject; a method of screening for a genetic suppressor of clk-1; and a method of screening for a genetic suppressor of coq-3.
申请公布号 CA2456565(A1) 申请公布日期 2003.02.20
申请号 CA20022456565 申请日期 2002.08.07
申请人 MCGILL UNIVERSITY;CHRONOGEN 发明人 GAO, YUAN;HEKIMI, SIEGFRIED;PAQUET, MICHEL;BENARD, CLAIRE;HIHI, ABDELMADJID;LEVAVASSEUR, FRANCOISE;SHOUBRIDGE, ERIC
分类号 A01K67/027;A01K67/033;A61K49/00;C12N5/10;C12N9/02;C12N9/10;C12N15/09;C12N15/85;C12Q1/02;C12Q1/26;G01N33/50;(IPC1-7):C12N15/12;A61K45/00;C12Q1/04;A01K67/02;C12Q1/00;C12N15/10;C12N15/90;C12N5/06 主分类号 A01K67/027
代理机构 代理人
主权项
地址